Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sphere Medical Holding's Enterprise Value is £-2.67 Mil.
Sphere Medical Holding's EBIT for the trailing twelve months (TTM) ended in Dec. 2016 was £-5.14 Mil. Therefore, Sphere Medical Holding's EV-to-EBIT ratio for today is 0.52.
Sphere Medical Holding Enterprise Value Historical Data
The historical data trend for Sphere Medical Holding's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sphere Medical Holding's Enterprise Value
For the Medical Devices subindustry, Sphere Medical Holding's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sphere Medical Holding's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sphere Medical Holding's Enterprise Value falls into.
Sphere Medical Holding Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Sphere Medical Holding's Enterprise Value for the fiscal year that ended in Dec. 2016 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sphere Medical Holding (LSE:SPHR) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sphere Medical Holding's current Enterprise Value is £-2.67 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sphere Medical Holding's EBIT for the trailing twelve months (TTM) ended in Dec. 2016 was £-5.14 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sphere Medical Holding's EV-to-EBITDA for today is:
Sphere Medical Holding's current Enterprise Value is £-2.67 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sphere Medical Holding's EBITDA for the trailing twelve months (TTM) ended in Dec. 2016 was £-4.99 Mil.
Sphere Medical Holding's current Enterprise Value is £-2.67 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sphere Medical Holding's Revenue for the trailing twelve months (TTM) ended in Dec. 2016 was £0.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sphere Medical Holding Enterprise Value Related Terms
Thank you for viewing the detailed overview of Sphere Medical Holding's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Sphere Medical Holding (LSE:SPHR) Business Description
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:SPHR has been successfully added to your 